Jonathan Hugh
About Jonathan Hugh
Jonathan Hugh serves as Acting Chief Executive Officer and Chief Financial Officer of ALT5 Sigma Corporation, assuming CEO duties effective October 16, 2025 while retaining the CFO role . He is the signatory on recent SEC filings communicating the Q3 2025 reporting delay and special meeting outcomes . Company performance context prior to his tenure is shown below.
| Metric | FY 2021 | FY 2022 | FY 2023 |
|---|---|---|---|
| Value of $100 Investment Based on TSR ($) | $83.64 | $33.50 | $40.88 |
| Net Income ($000s) | $(16,887) | $10,992 | $(7,812) |
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| ALT5 Sigma Corporation | Acting Chief Executive Officer | Oct 16, 2025–present | Assumed CEO duties and signed SEC items including special meeting vote disclosure and Q3 reporting updates |
| ALT5 Sigma Corporation | Chief Financial Officer | 2025–present (as evidenced by filings) | Principal financial officer and SEC signatory on DEFA14A/8-Ks and NT 10-Q, leading external reporting communications |
External Roles
No external public company directorships or roles were disclosed in the reviewed filings for Jonathan Hugh .
Equity Ownership & Alignment
| Item | As-of | Value/Details |
|---|---|---|
| Common shares beneficially owned | Aug 12, 2025 | Not reported in beneficial ownership table for Jonathan Hugh |
| Ownership as % of common | Aug 12, 2025 | Not reported |
| Ownership as % of total voting power | Aug 12, 2025 | Not reported |
| Hedging policy | FY 2024 | Company prohibits directors, officers, and employees from engaging in hedging transactions |
| Officer/director lock-up restrictions | Aug–Oct 2025 | Officers and directors agreed to lock-ups: 50% of shares limited for 90 days post resale registration effective date; remaining 50% limited until the later of 90 days post-effective date or effective date of stockholder approvals in the special proxy |
Employment Terms
- Equity Plan governance: The 2024 Equity Incentive Plan provides termination and change-of-control mechanics applicable to executive awards, including full vesting/exercisability for options/SARs not assumed upon a change-of-control and pro-rata vesting of performance-based equity under certain conditions . Termination provisions define treatment for death/disability, retirement, and other terminations (including for-cause cancellations) .
- Anti-hedging: Directors and officers are prohibited from hedging Company securities per policy .
Vesting Schedules and Insider Selling Pressure
| Constraint | Details |
|---|---|
| Officer/director lock-up | 50% of shares restricted for 90 days after resale registration effective date; remaining 50% restricted until the later of 90 days after the effective date or stockholder approvals of proxy matters |
Compensation Structure
Specific compensation data for Jonathan Hugh (base salary, target/actual bonus, RSUs/PSUs/options) was not disclosed in the reviewed filings .
Governance & Shareholder Votes (Context)
| Proposal | Votes For | Votes Against | Abstentions | Outcome |
|---|---|---|---|---|
| Increase authorized common shares to 2,000,000,000 | 56,829,178 | 13,099,874 | 4,646 | Approved |
Performance & Track Record
- Reporting oversight: As Acting CEO and CFO, Hugh signed the NT 10-Q indicating the Company had not completed Q3 financials and could not estimate results; the Company reiterated the delay in an 8-K Other Events filing .
- Role transition: Assumed CEO duties from the suspended prior CEO effective October 16, 2025 .
Risk Indicators & Red Flags
- Dual role concentration: Combined Acting CEO and CFO responsibilities amid a reporting delay elevates execution and control risk .
- Ownership alignment: No beneficial ownership for Jonathan Hugh was reported as of Aug 12, 2025, which may indicate limited personal equity alignment at that date .
- Potential dilution dynamics: The WLFI-related private placement contemplates warrant exercises that could have resulted in ~52% of outstanding common stock to the Lead Investor if beneficial ownership limits were disregarded, underscoring dilution risk for existing holders .
Investment Implications
- Alignment: The absence of reported share ownership for Hugh as of Aug 12, 2025, coupled with no disclosed personal compensation details, limits pay-for-performance visibility; however, officer/director lock-ups mitigate near-term selling pressure if/when equity awards/shares are held .
- Governance/Execution: Dual Acting CEO/CFO status during delayed reporting signals elevated operational risk; monitor subsequent 10-Q/10-K filings, any compensation disclosures, and insider Forms 3/4/5 to reassess alignment and retention risk .
- Structural risk: Share authorization increases and WLFI warrant constructs highlight ongoing dilution and control dynamics; continued scrutiny of capital structure actions and investor rights is warranted .